Let's get the sticker shock out of the way first: if you walk into a pharmacy without insurance and ask to fill a prescription for Wegovy, you'll be looking at roughly $1,300 per month. Ozempic runs about $900–$1,000. Mounjaro (tirzepatide) lands somewhere around $1,000–$1,200. These are list prices — the numbers pharmaceutical companies set before any discounts, negotiations, or coverage kick in.

The good news? Almost nobody actually pays list price. The bad news? Navigating the real cost landscape requires understanding a maze of insurance tiers, manufacturer coupons, compounding pharmacies, and telehealth platforms. Let's break it all down.

Retail Prices: The Numbers Nobody Should Be Paying

Here's what the brand-name GLP-1 medications cost at full retail in 2025:

  • Ozempic (semaglutide, 0.25–1mg): ~$900–$1,050/month. FDA-approved for type 2 diabetes, often prescribed off-label for weight loss.
  • Wegovy (semaglutide, 2.4mg): ~$1,300/month. FDA-approved specifically for weight management.
  • Mounjaro (tirzepatide, 2.5–15mg): ~$1,000–$1,200/month. FDA-approved for type 2 diabetes; its weight-loss counterpart Zepbound is similarly priced.
  • Zepbound (tirzepatide, for weight loss): ~$1,050–$1,200/month. Eli Lilly's dedicated weight-management version of tirzepatide.

These prices are why GLP-1 medications have dominated health policy conversations. At $15,000+ per year, the math only works at scale if insurance covers it — and that's where things get complicated.

Insurance Coverage: A Rapidly Shifting Landscape

Insurance coverage for GLP-1 weight-loss medications varies dramatically by plan, employer, and state. Here's the general picture:

If you have a diabetes diagnosis: Coverage for Ozempic and Mounjaro is relatively common. Most commercial insurance plans and Medicare Part D cover these as diabetes medications, often with copays ranging from $25 to $150/month after meeting your deductible. The path is well-established because these drugs were originally approved for blood sugar control.

If you want coverage for weight loss: This is where it gets harder. Wegovy and Zepbound are approved for chronic weight management, but many insurance plans still classify weight-loss medications as "lifestyle" or "cosmetic" and exclude them entirely. As of early 2025, roughly 40–50% of commercial insurance plans offer some coverage for anti-obesity medications, up from about 25% just two years ago. The trend is moving in the right direction, but there are still major gaps.

Medicare: As of 2025, Medicare does not cover drugs prescribed solely for weight loss. The Treat and Reduce Obesity Act has been introduced in Congress multiple times to change this, but it hasn't passed yet. If you have Medicare and a type 2 diabetes diagnosis, you can get Ozempic or Mounjaro covered — but not Wegovy for weight management alone.

Medicaid: Coverage varies by state. Some state Medicaid programs cover anti-obesity medications; many don't. Check your specific state's formulary.

Manufacturer Savings Cards and Coupons

Both Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Mounjaro/Zepbound) offer savings programs for commercially insured patients. These can reduce your out-of-pocket cost to as low as $0–$25/month — but there are restrictions:

  • You typically need commercial insurance (not Medicare, Medicaid, or government plans)
  • There are usually annual caps on savings (e.g., $500/month max savings, up to a yearly limit)
  • The programs can change or expire — Novo Nordisk has adjusted its Wegovy savings program multiple times

If you have commercial insurance with any level of GLP-1 coverage, always check the manufacturer's savings program first. It can be the difference between a $300 copay and a $25 copay.

Compounded Semaglutide: The $200–$400/Month Alternative

This is where the market has gotten interesting — and controversial. Compounded semaglutide refers to versions of the drug made by compounding pharmacies rather than by Novo Nordisk. Under FDA regulations, compounding pharmacies can produce copies of drugs that are on the FDA's shortage list, which semaglutide has been intermittently since 2022.

Compounded semaglutide typically costs $200–$400 per month, depending on the dose and provider. That's a fraction of the brand-name price. Many telehealth platforms (more on those below) have built their entire business model around prescribing compounded semaglutide.

Important caveats:

  • Legal status is fluid. The FDA has moved to remove semaglutide from the shortage list, which would affect compounding pharmacies' ability to produce it. Legal challenges from compounding pharmacies and telehealth companies have created uncertainty. As of early 2025, compounded semaglutide remains available through many providers, but the regulatory landscape could shift.
  • Quality varies. Compounded medications aren't subject to the same manufacturing standards as FDA-approved drugs. Most reputable compounding pharmacies produce high-quality product, but there have been reports of dosing inconsistencies and contamination from less scrupulous operations. Always verify that your compounding pharmacy is accredited (look for PCAB accreditation).
  • It's the same molecule. When properly compounded, the active ingredient is identical to what's in Ozempic or Wegovy. The difference is in manufacturing oversight, not chemistry.

Telehealth Providers: The New Front Door

A growing number of telehealth platforms now specialize in prescribing GLP-1 medications. These services typically offer an online consultation with a licensed provider, ongoing monitoring, and either a prescription you fill at a pharmacy or direct-shipped compounded medication. Some of the major players:

  • Hims / Hers: Offers compounded semaglutide starting around $199/month. Includes provider consultations and ongoing support.
  • Ro: Provides both brand-name and compounded options. Pricing varies based on medication and insurance status.
  • Found: Takes an integrated approach with medication, coaching, and behavioral support. Pricing depends on the prescribed medication.

Telehealth platforms have made GLP-1 access dramatically easier — no waiting weeks for an endocrinologist appointment, no awkward conversations with a skeptical primary care doctor. For many people, especially those without obesity-friendly insurance coverage, these platforms represent the most practical path to treatment.

What to watch out for:

  • Make sure the platform uses licensed providers in your state
  • Understand whether you're getting brand-name or compounded medication
  • Check if the price includes provider consultations or if those are billed separately
  • Ask about their protocol if you experience side effects — good platforms offer responsive clinical support, not just a prescription mill

The Cost-Per-Pound-Lost Analysis

Here's a framework most people don't think about: what does each pound of weight loss actually cost? Let's run the math for a typical user — someone who loses 35 lbs over 9 months on semaglutide.

  • Brand-name Wegovy with insurance ($150/mo copay): $1,350 total → ~$39 per pound lost
  • Brand-name Wegovy with savings card ($25/mo): $225 total → ~$6.40 per pound lost
  • Compounded semaglutide via telehealth ($250/mo): $2,250 total → ~$64 per pound lost
  • Full retail Wegovy, no coverage ($1,300/mo): $11,700 total → ~$334 per pound lost

For context, bariatric surgery costs $15,000–$35,000 and produces average weight loss of 60–120 lbs, working out to $150–$500 per pound lost — but with surgical risks, recovery time, and permanent anatomical changes. Commercial weight-loss programs (Noom, WW, etc.) cost $200–$500/year but produce average losses of only 5–10 lbs, putting them at $20–$100 per pound — and the weight typically comes back.

The point isn't that GLP-1 medications are cheap. They're not. But per pound of sustained weight loss, they're remarkably cost-effective compared to historical alternatives, especially at the insurance or compounded price points. For a deeper look at the clinical data behind these weight-loss numbers, see our semaglutide clinical data breakdown.

Practical Steps to Minimize Your Cost

  1. Check your insurance formulary first. Call the number on the back of your card and ask specifically about Wegovy, Zepbound, Ozempic, and Mounjaro. Ask about prior authorization requirements.
  2. Apply for manufacturer savings programs. Even with insurance, these can dramatically reduce copays.
  3. Consider compounded options. If insurance won't cover brand-name, compounded semaglutide through a reputable telehealth platform can cut costs by 70–80%.
  4. Ask about step therapy. Some insurers will cover GLP-1 medications if you've tried and failed other interventions first. Your doctor can document this.
  5. Use your HSA/FSA. GLP-1 medications prescribed for weight loss or diabetes are typically eligible expenses for Health Savings Accounts and Flexible Spending Accounts.

The cost barrier is real, but it's lower than most people think — especially once you move beyond the headline list prices. And if you're curious what GLP-1 weight loss might actually look like for your body before investing, try the MeOnGLP transformation tool — it takes 60 seconds and costs nothing.